Barclays’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $909K | Buy |
|
|||||
|
2025
Q1 | $474K | Sell |
|
|||||
|
2024
Q4 | $518K | Sell |
|
|||||
|
2024
Q3 | $923K | Buy |
|
|||||
|
2024
Q2 | $853K | Buy |
|
|||||
|
2024
Q1 | $1.46M | Sell |
|
|||||
|
2023
Q4 | $4.27M | Sell |
|
|||||
|
2023
Q3 | $4.25M | Buy |
|
|||||
|
2023
Q2 | $6.77M | Sell |
|
|||||
|
2023
Q1 | $6.17M | Buy |
|
|||||
|
2022
Q4 | $3.67M | Sell |
|
|||||
|
2022
Q3 | $4.13M | Buy |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $1.24M | Sell |
|
|||||
|
2021
Q4 | $2.69M | Buy |
|
|||||
|
2021
Q3 | $2.24M | Buy |
|
|||||
|
2021
Q2 | $1.61M | Sell |
|
|||||
|
2021
Q1 | $4.83M | Buy |
|
|||||
|
2020
Q4 | $347K | Buy |
|
|||||
|
2020
Q3 | $233K | Sell |
|
|||||
|
2020
Q2 | $741K | Sell |
|
|||||
|
2020
Q1 | $2.78M | Sell |
|
|||||
|
2019
Q4 | $7.83M | Buy |
|
|||||
|
2019
Q3 | $5.05M | Buy |
|
|||||
|
2019
Q2 | $3.47M | Buy |
|
|||||
|
2019
Q1 | $330K | Sell |
|
|||||
|
2018
Q4 | $4.27M | Buy |
|
|||||
|
2018
Q3 | $1.78M | Sell |
|
|||||
|
2018
Q2 | $9.62M | Buy |
|
|||||
|
2018
Q1 | $1.61M | Sell |
|
|||||
|
2017
Q4 | $33.7M | Buy |
|
|||||
|
2017
Q3 | $2.01M | Sell |
|
|||||
|
2017
Q2 | $14.4M | Buy |
|
|||||
|
2017
Q1 | $88K | Sell |
|
|||||
|
2016
Q4 | $3.48M | Buy |
|
|||||
|
2016
Q3 | $19K | Sell |
|
|||||
|
2016
Q2 | $1.46M | Buy |
|
|||||
|
2016
Q1 | $77K | Buy |
|
|||||
|
2015
Q4 | $33K | Sell |
|
|||||
|
2015
Q3 | $516K | Buy |
|
|||||
|
2015
Q2 | $121K | Buy |
|
|||||
|
2015
Q1 | $24K | Sell |
|
|||||
|
2014
Q4 | $21K | Buy |
|